Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Dezocine is a partial opiate drug and is used for pain management. Dezocine is a very effective alternative to fentanyl when administered during outpatient laparoscopy, although is associated with an...
- Mechanism
- Curator reviewed
Dezocine is a opioid analgesic drug of mixed agonist-antagonist type. It binds with stereospecific receptors at many sites within the central nervous system (CNS) to alter processes affecting both the perception of pain and the emotional response to pain. At least 2 of these types of receptors (mu and kappa) mediate analgesia. Mu receptors are widely distributed throughout the CNS, especially in the limbic system (frontal cortex, temporal cortex, amygdala, and hippocampus), thalamus, striatum, hypothalamus, and midbrain as well as laminae I, II, IV, and V of the dorsal horn in the spinal cord. Kappa receptors are localized primarily in the spinal cord and in the cerebral cortex.
- Primary indication
- Indicated in the treatment of moderate to severe pain.Curator reviewed
- Formula / weight
- C16H23NO · 245.3599 g/mol (avg)
- Code names
- WY-16,225
Resolves to
VTMVHDZWSFQSQP-VBNZEHGJSA-NSMILES[H][C@@]12CC3=CC=C(O)C=C3[C@@](C)(CCCCC1)[C@H]2NWhat you can answer from here — as of September 23, 2026
Which drugs share a target with Dezocine, and which of those have an active Phase 3 trial?